COVIDSHIELD

First consignment of Covishield vaccine arrives in Bengaluru

The health department officials received the consignment which was then transported to the government cold storage facility in the health o...

View: Why vaccine scaremongering is unhelpful

India still remains vulnerable to a national second or third wave of attacks and a fair amount of luck also appears to have played a part i...

View: Shouldn't we look before we take a leap on Covid vaccination?

For a mass roll-out of vaccines, the world is looking at India, the largest supplier of vaccines. So, when India gave ‘restricted emergency...

Covishield and Covaxin: All you need to know about the DCGI-approved vaccines

ET rounds up facts and some questions on Covishield and Covaxin, approved by DCGI on Sunday

India may authorise some COVID-19 vaccines in weeks, says health secretary

Six vaccines, including Astra Zeneca's Covidshield and Bharat Biotech's Covaxin, are in trial stages, Federal health secretary Rajesh Bhush...

Adar Poonawalla, CEO of Serum Institute, named 'Asian of the Year' with 6 others

SII has collaborated with Oxford University and AstraZeneca for making the COVID-19 vaccine.

Serum Institute likely to sell Covid vaccine in private market by March-April

The initial supply in the open market will cater to large bulk orders. Eventually, the vaccine will be available to individuals too.

Initial findings into 'adverse event' did not necessitate halting of trials: Govt

A 40-year-old man who was a volunteer in the third phase of the ''Covidshield'' vaccine trial in Chennai has alleged serious side effects, ...

Serum Institute rejects charges levelled by vaccine trial participant, will seek Rs 100 crore in damages

A 40-year-old man who took part in the 'Covidshield' vaccine trial in Chennai has alleged serious side effects, including a virtual neurolo...

Centre may purchase 300-400 million Covishield doses by July 2021: Adar Poonawalla

SII has partnered with global pharma giant AstraZeneca and Oxford University for the vaccine candidate 'Covidshield'. "As of now we don't h...

Serum Institute of India seeks DCGI permission for phase 2/3 clinical trials of Oxford's COVID 'vaccine'

The sources told that the Pune-based drug firm submitted its application to the DCGI on Friday seeking permission for conducting the trials...